Ikemoto, Tomokazu <br/><br/>
Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases.  [electronic resource] 

 -  Heart and vessels  Jul 2012 
 - 344-51 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1615-2573 
<br/><br/><label>Standard No.: </label>10.1007/s00380-011-0163-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Antigens, CD--blood<br/>Biomarkers--blood<br/>Cardiovascular Diseases--blood<br/>Cells, Cultured<br/>Cellular Senescence<br/>Chi-Square Distribution<br/>Chronic Disease<br/>Coronary Artery Disease--blood<br/>Death, Sudden, Cardiac--etiology<br/>Endoglin<br/>Female<br/>Heart Failure--etiology<br/>Human Umbilical Vein Endothelial Cells--immunology<br/>Humans<br/>Hydrogen Peroxide--metabolism<br/>Inflammation Mediators--metabolism<br/>Japan<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Myocardial Infarction--etiology<br/>Proportional Hazards Models<br/>Receptors, Cell Surface--blood<br/>Risk Assessment<br/>Risk Factors<br/>Stroke--etiology<br/>Time Factors<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Up-Regulation